The Effect of Cuprophane Hemodialyzer Treated with Plasma and Albumin on Leukocyte Count

인공신에 의한 백혈구 수의 변화 혈장 및 알부민의 전처치가 이에 미치는 영향

It is now well established that transient granulocytopenia is common in patients during the initial phase of hemodialysis with new cuprophane membrane, but not with reused nembrane, or some synthetic membranes. In this study, new cuprophane dialyzer was treated with plasma and albumin, respectively, then, peripheral blood leukocytes were counted at the onset and after 15 minute of hemodialysis. In the plasma-treated group, the percent of leukopenia was less (41.3 %) than control group (71.3 %). In the plasmatreated group, the degree of leukopenia was close to that ot'control grou p. The protective factor, therefore is thought to be present in the plasma other than albumin fraction.